Evaluation of chemosensitivity prediction using quantitative dose–response curve classification for highly advanced/relapsed gastric cancer


BACKGROUND The use of standard chemotherapy regimens has changed the application of chemosensitivity tests from all chemotherapy-eligible patients to those who have failed standard chemotherapy, which includes patients with highly advanced, relapsed, or chemoresistant tumors. METHODS We evaluated a total of 43 advanced primary and relapsed gastric cancers… (More)
DOI: 10.1186/1477-7819-11-11


7 Figures and Tables